Rossari Biotech Ltd.

NSE: ROSSARI | BSE: 543213 | ISIN: INE02A801020 | Industry: Specialty Chemicals
| Mid-range Performer
609.1000 -2.30 (-0.38%)
NSE Mar 20, 2025 13:30 PM
Volume: 52,697
 

609.10
-0.38%
Anand Rathi
We expect it is likely to deliver 18%/22%/25% revenue/EBITDA/PAT CAGRs over FY25-27 due to swelling demand, capacity expansion and mounting exports.
Rossari Biotech Ltd. has an average target of 939.75 from 4 brokers.
More from Rossari Biotech Ltd.
Recommended